Showing results (211-220 of 223) with videos related to

Sort By:
Pageof 23
Neurology|May 30, 2014
Defining the clinical course of multiple sclerosis: the 2013 revisionsFred D Lublin, Stephen C Reingold, Jeffrey A Cohen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2017
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disabilityNicholas G LaRocca, Lynn D Hudson, Richard Rudick, et al.
Neurology|June 12, 2026
Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter StudyAlexandra Scharf, Jeffrey A Cohen, Ruth Ann Marrie, et al.
JCI Insight|November 25, 2025
Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trialMeggan Mackay, Catriona A Wagner, Ashley Pinckney, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2025
Prospective SARS-CoV-2 Booster Vaccination in Immunosuppressant-Treated Systemic Autoimmune Disease Patients in a Randomized Controlled TrialMeggan Mackay, Catriona A Wagner, Ashley Pinckney, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 15, 2020
COVID-19 in people with multiple sclerosis: A global data sharing initiativeLiesbet M Peeters, Tina Parciak, Clare Walton, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 31, 2026
Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS)Emma C Tallantyre, Sarah M Planchon, Harriet Howard, et al.
The Lancet. Neurology|September 20, 2025
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteriaXavier Montalban, Christine Lebrun-Frénay, Jiwon Oh, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 30, 2019
Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSDLawrence J Cook, John W Rose, Jessica S Alvey, et al.
JAMA Neurology|March 11, 2025
Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial, Jinsy Andrews, Sabrina Paganoni, et al.
Pageof 23